Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 28, 2014; 20(8): 1935-1939
Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.1935
Intra-operative peritoneal lavage for colorectal cancer
Guillaume Passot, Kayvan Mohkam, Eddy Cotte, Olivier Glehen
Guillaume Passot, Kayvan Mohkam, Eddy Cotte, Olivier Glehen, Departement of General and Surgical Oncology, Hospices Civils de Lyon, 69495 Pierre Bénite, France
Guillaume Passot, Kayvan Mohkam, Eddy Cotte, Olivier Glehen, EMR 3738, Université Lyon 1, F-69364 Lyon, France
Author contributions: All authors contributed to the design and editing for the manuscript; Mohkam K and Passot G wrote the article.
Correspondence to: Olivier Glehen, MD, PhD, Departement of General and Surgical Oncology, Hospices Civils de Lyon, CH Lyon Sud, 69495 Pierre Bénite, France. olivier.glehen@chu-lyon.fr
Telephone: +33-7-8865742 Fax: +33-7-8863343
Received: September 27, 2013
Revised: November 28, 2013
Accepted: January 6, 2014
Published online: February 28, 2014
Core Tip

Core tip: We provide an overview of intraperitoneal free cancer cells (IPCC) detection and its impact on recurrence and survival, and we suggest further multi-institutional studies to evaluate new treatment strategies. Moreover, while current literature is sufficient to consider positive IPCC as a pejorative prognostic factor, further studies are also needed to propose adjuvant treatment for patients with positive IPCC.